Analysis of high-value medical supplies price setting policy under the disease fee payment system reform in China: A case of Endoscopic Retrograde Cholangio-Pancreatography (ECRP)
10.3969/j.issn.1674-2982.2017.06.009
- VernacularTitle:按病种付费下高值医用耗材医疗服务价格政策现状、影响及建议——以经内镜逆行性胰胆管造影术(ECRP)为例
- Author:
Yingmin WU
;
Maojuan HUANG
;
Tian REN
;
Mei ZHANG
- Keywords:
ERCP;
Hospitalization expense;
Disease payment system;
Price policy
- From:
Chinese Journal of Health Policy
2017;10(6):49-53
- CountryChina
- Language:Chinese
-
Abstract:
This paper analyzes the ERCP price setting policy and its impact on the patient''s cost and it puts forward possible price setting policy recommendations, according to the current situation of the disease payment system reform and promotion prospects of ERCP.ERCP belongs to the low-price high-value medical supplies, but hospitalization expenses data of 9 types of diseases show that consumables accounted for 35.81~48.25%.The main factor hindering widely the application of ERCP lies in high-ratio self-payment and high medical cost, in other words, as the ERCP supplies are not included in the scope of medical insurance payments, the current rate of patients with high surgical expenses, medical costs are expensive.As per the analysis of this paper, the following are the policy recommendations to put forward 1)Paying attention to historical settlement data and scientific formulation of disease charges;2)Considering different treatment methods and allocate appropriate disease payment standards;3)Standardize operation code to ensure the information quality of accurate disease expenses calculation.
